0IGA.L - Emergent BioSolutions Inc.

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-75.80%
S&P500 52-week change 31.77%
52-week high 334.64
52-week low 37.78
50-day moving average 39.66
200-day moving average 316.12

Share statistics

Avg vol (3-month) 32.39k
Avg vol (10-day) 31.71k
Shares outstanding 550.95M
Implied shares outstanding 6N/A
Float 845.36M
% held by insiders 10.76%
% held by institutions 195.52%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin -41.20%
Operating margin (ttm)-32.18%

Management effectiveness

Return on assets (ttm)-6.87%
Return on equity (ttm)-29.02%

Income statement

Revenue (ttm)978.5M
Revenue per share (ttm)19.58
Quarterly revenue growth (yoy)-46.30%
Gross profit (ttm)236.8M
EBITDA -173.2M
Net income avi to common (ttm)-403.1M
Diluted EPS (ttm)2.97
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)436.1M
Total cash per share (mrq)8.65
Total debt (mrq)1.41B
Total debt/equity (mrq)117.64
Current ratio (mrq)1.00
Book value per share (mrq)23.86

Cash flow statement

Operating cash flow (ttm)-180.8M
Levered free cash flow (ttm)-202.89M